Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event

Rhea-AI Summary

Miromatrix Medical Inc. (NASDAQ: MIRO) announced that CEO Jeff Ross will present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event on September 28-29, 2022. The event focuses on advancements in kidney transplants on the first day and innovations in hematopoietic stem cell transplants on the second. Ross's presentation is scheduled for September 28 at 10:00 am CT. Miromatrix specializes in bioengineering fully transplantable organs, particularly focusing on human livers and kidneys to address organ shortages.

EDEN PRAIRIE, Minn., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced CEO Jeff Ross will present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event. The two-day virtual event held this year on September 28-29, will focus the first day on solid organ transplant (SOT), in particular, kidney transplants, and the second day on the unmet need and innovations in hematopoietic stem cell transplant (HSCT).

Mr. Ross will be presenting at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event on September 28^th, 2022 at 10:00 am CT. Registration for the event can be found here.

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

FAQ

What will Jeff Ross discuss at the MIRO event on September 28, 2022?

Jeff Ross will present on advancements in kidney transplants at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event.

When is the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event?

The event is scheduled for September 28-29, 2022.

What is Miromatrix's focus in bioengineering?

Miromatrix is focused on bioengineering fully transplantable human organs, specifically livers and kidneys.

How can I register for the MIRO virtual event?

Registration for the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event can be found in the press release.

What is the significance of Miromatrix's technology in organ transplants?

Miromatrix's technology aims to address the shortage of available human organs through bioengineering.